Zobrazeno 1 - 10
of 77
pro vyhledávání: '"N V, Lyubimova"'
Autor:
N. V. Lyubimova, Yu. S. Timofeev, A. V. Lebedeva, A. V. Artamonova, I. S. Stilidi, N. E. Kushlinskii
Publikováno v:
Успехи молекулярной онкологии, Vol 9, Iss 4 (2022)
Introduction. Carcinoid syndrome is the most common functional syndrome in patients with neuroendocrine tumors. More than 40 biochemical factors are responsible for the manifestation of carcinoid syndrome, among which serotonin is the most important.
Externí odkaz:
https://doaj.org/article/2a33f594a7594d72a7334795ad42bd17
Publikováno v:
Успехи молекулярной онкологии, Vol 8, Iss 3, Pp 8-13 (2021)
Introduction. Immunoenzyme assay of biochemical markers is one of the most important methods for examination of pa- tients with neuroendocrine tumors (NETs). Along with the generally accepted NET marker chromogranin A (CgA), another member of the gra
Externí odkaz:
https://doaj.org/article/abd9af006e9742398414eb8858acfb66
Publikováno v:
Успехи молекулярной онкологии, Vol 7, Iss 1, Pp 32-37 (2020)
Background. Tumors of stroma of the sex cord include a family of tumors that are diverse in structure and biological characteristics, including hormone-active ovarian tumors, such as granulosa cell tumor (GCT) of the ovary and a tumor from Sertoli–
Externí odkaz:
https://doaj.org/article/9ce6270412e74e63b20340d198bf5a40
Autor:
N. V. Lyubimova, Yu. S. Timofeev, T. K. Churikova, A. A. Markovich, G. S. Emelianova, I. S. Stilidi, N. E. Kushlinskii
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 47, Iss 8, Pp 685-690 (2020)
Background: The utility of biochemical markers in the monitoring of treatment efficacy in patients with neuroendocrine tumors (NETs) goes beyond any doubt. However, there are still no clear criteria for the assessment of clinically significant abnorm
Externí odkaz:
https://doaj.org/article/97c8e18912514a1484b43ce46583cc2c
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 46, Iss 3, Pp 264-269 (2018)
Rationale: Biochemical diagnostics of neuroendocrine tumors (NETs) is based on the analysis of universal and specific markers, according to the tumor type and clinical manifestations of the disease. Measurement of gastrin levels in the serum of NETs
Externí odkaz:
https://doaj.org/article/bd11a4d0d4df4e2a96deee3374a2a54d
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 45, Iss 2, Pp 102-108 (2017)
Background: Analysis of free light chains of immunoglobulins (FLC) in the serum is an effective method in the diagnosis of multiple myeloma. Plasma cells produce two types of FLC: κand λ-FLC. FLC, which are not incorporated into monoclonal intact i
Externí odkaz:
https://doaj.org/article/17548276f8ab4aa8907330718865836c
Autor:
N. V. Lyubimova, A. E. Kuz’minov, A. A. Markovich, A. V. Lebedeva, Yu. S. Timofeev, I. S. Stilidi, N. E. Kushlinskii
Publikováno v:
Bulletin of Experimental Biology and Medicine. 173:257-260
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::583d20c8301bdcb12b756e1f3a868a9b
https://doi.org/10.1007/s10517-022-05529-9
https://doi.org/10.1007/s10517-022-05529-9
Autor:
N. V. Lyubimova, N. E. Kushlinskii
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 44, Iss 4, Pp 439-450 (2016)
This review summarizes current data on neuroendocrine tumors (NET), which, unlike other neoplasms, are able to produce biologically active substances (hormones, vasoactive peptides, amines). It is exactly their main characteristic that allows to unif
Externí odkaz:
https://doaj.org/article/b6bcc52611264a1ba8e976c0e97164de
Autor:
T. A. Мitina, A. K. Golenkov, A. Yu. Baryshnikov, A. V. Karaulov, E. V. Trifonova, Yu. B. Chernykh, E. V. Katayeva, T. D. Lutskaya, L. L. Vysotskaya, G. A. Dudina, S. G. Zacharov, A. M. Fomin, N. V. Lyubimova, I. N. Kogarko
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 0, Iss 29, Pp 33-37 (2016)
Efficiency of the multiple myeloma treatment with chemotherapy including bortezomib was assessed based on determination of the level of immunoglobulin free light chains in blood serum. The method enables estimation of changes in kinetic parameters of
Externí odkaz:
https://doaj.org/article/05d3dfcce4404fb0a35c81461490811c
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 0, Iss 41, Pp 35-39 (2016)
Background: Neuroendocrine tumors (NET) is a heterogeneous group of neoplasms characterized by hypersecretion of biologically active sub- stances that manifests by specific syndromes and determines the clinical course of the disease. The most common
Externí odkaz:
https://doaj.org/article/0510c9d8f2834c3298cdc239883a416b